Inventor · disambiguated record
Peter Clarke
Also filed as: CLARKE PETER · CLARKE PETER B
2 granted patents·9 pending applications·17 citations·filing 1997–2020
57Inventor score
Files withINTROGEN THERAPEUTICS INC6PHAM HAI1PSIOXUS THERAPEUTICS LTD1RESURGO GENETICS LTD1ZHANG SHUYUAN1
Top patents by PatentIndex Score
11 records- 0171US9428768B2Method for the production and purification of adenoviral vectorsPHAM HAI·Filed 2009·Granted Aug 30, 2016·2 cites·28 claims
- 0257US2006275781A1Novel method for the protection and purification of adenoviral vectorsINTROGEN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 0351US2009253184A1Compositions and methods related to an adenoviral trans-complementing cell lineINTROGEN THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 0450US5983760AInline skate key assemblyFiled 1997·Granted Nov 16, 1999·15 cites·6 claims
- 0546US2007172846A1Methods for the Production and Purification of Adenoviral VectorsINTROGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0645US2008299545A1Chromatographic methods for assessing adenovirus purityZHANG SHUYUAN·Filed 2008·Application pending·0 cites
- 0744US2010209451A1Compositions and Methods Related to Adenovirus Based Delivery of AntigensINTROGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 0844US2008044378A1Methods and Compositions for Protein Production Using Adenoviral VectorsINTROGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 0944US2022340885A1Method of purifying a composition comprising a group b adenovirusPSIOXUS THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1042US2007066552A1Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acidsINTROGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1141US2021163930A1Methods of changing transcriptional outputRESURGO GENETICS LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Clarke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →